{"title":"恢复期血浆治疗(CPT)加瑞姆德西韦与标准治疗(瑞姆德西韦)对缅甸第二波和第三波COVID-19严重或危重感染患者的疗效:非随机介入研究","authors":"Phyu Pyar K","doi":"10.51737/2766-5003.2022.028","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":237254,"journal":{"name":"SunText Review of Virology","volume":"37 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Efficacy of Convalescent Plasma Therapy (CPT) plus Remdesivir versus Standard Therapy (Remdesivir) In Patients with Severe or Critical COVID-19 Infection in Second and Third Wave of Epidemics in Myanmar: Non-Randomized Interventional Study\",\"authors\":\"Phyu Pyar K\",\"doi\":\"10.51737/2766-5003.2022.028\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":237254,\"journal\":{\"name\":\"SunText Review of Virology\",\"volume\":\"37 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1900-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"SunText Review of Virology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.51737/2766-5003.2022.028\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"SunText Review of Virology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.51737/2766-5003.2022.028","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Efficacy of Convalescent Plasma Therapy (CPT) plus Remdesivir versus Standard Therapy (Remdesivir) In Patients with Severe or Critical COVID-19 Infection in Second and Third Wave of Epidemics in Myanmar: Non-Randomized Interventional Study